Miles Boykin led Notre Dame with 59 catches for 872 yards and eight touchdowns during his senior year, which ended with a ...

Purdue football's early 2026 recruiting momentum on the offensive line continued Saturday. East St. Louis (Illinois) offensive tackle Terrell Berryhill Jr. committed to the Boilermakers following ...

Douglas Buckeridge (3000m steeplechase) and Antoine Spencer (200m) led the way for Purdue Outdoor Track & Field on Friday with victories in their respective events.

Purdue has extended an offer to 2028 center Erick Dampier Jr., a 6-foot-10, 230-pound prospect. He now has two offers from Division I programs.

Trey Kaufman-Renn made major improvements from his sophomore to junior season. Where can his game continue to evolve? He answered that question.

What happens to Purdue's name, image and likeness collectives and fundraising? Here are five frequently asked questions about the future of Boilermakers sports.

Jim Bullard, dean of the Mitch Daniels School of Business at Purdue University, answers questions Thursday from The Times Executive Editor Kathy Chaney at the annual Business & Industry Hall of ...

WASHINGTON — Purdue Pharma has gained support from attorneys general in 55 U.S. states and territories for a $7.4 billion settlement aimed at resolving thousands of lawsuits related to the ...

Max Carmicle marks the fifth defensive commitment of the 2026 class. Purdue football added to its 2026 recruiting class Thursday by taking an edge rusher away from another Midwestern program.

Antione West Jr. is a talented combo guard and is just one of two incoming freshmen in the 2025 class. How could he help the Boilermakers this coming season?

The Purdue University Books Initiative continues its monthly webinar series featuring global publishing houses. Faculty and staff are invited to attend the Emerald Publishing webinar at 11 a.m.

Purdue Pharma has won support from the attorneys general of 55 U.S. states and territories for its $7.4 billion settlement to resolve thousands of opioid lawsuits against the drugmaker and its ...